A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. 1993

K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
Division of Cell Biology, Burroughs Wellcome Co., Research Triangle Park, North Carolina.

Four different opioid receptor binding assays and three different isolated tissue studies were used to screen for delta receptor-selective nonpeptidic compounds. (+/-)-4-((alpha-R*)-alpha-((2S*,5R*)-4-Allyl-2,5- dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N,N-diethylbenzamide (BW373U86) was a potent delta receptor-selective ligand in receptor binding assays. The Ki values were 1.8 +/- 0.4, 15 +/- 3, 85 +/- 4 and 34 +/- 3 nM for delta, mu, epsilon and kappa receptor binding sites, respectively. BW373U86 inhibited electrically evoked muscle contraction of mouse vas deferens with an ED50 value of 0.2 +/- 0.06 nM. This inhibitory effect of BW373U86 was antagonized by the delta receptor-selective antagonist naltrindole in a competitive manner: the Schild plot indicated a slope of 1 and a pA2 value of 9.43 (Ke = 3.7 x 10(-10) M), which is consistent with the high affinity of naltrindole in delta receptors. BW373U86 did not interact significantly with other receptors. BW373U86 inhibited the acoustic startle reflex after subcutaneous administration from 0.2- to 2-mg/kg doses in rats, and this inhibition was blocked by naltrindole. BW373U86 also induced a dose-dependent increase of locomotor activity in rats at similar doses. This effect was inhibited by naltrindole. These data suggest that BW373U86 is a potent and selective nonpeptidic delta agonist, and it elicits distinct in vivo pharmacological activities.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008124 Locomotion Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms. Locomotor Activity,Activities, Locomotor,Activity, Locomotor,Locomotor Activities
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009619 Nociceptors Peripheral AFFERENT NEURONS which are sensitive to injuries or pain, usually caused by extreme thermal exposures, mechanical forces, or other noxious stimuli. Their cell bodies reside in the DORSAL ROOT GANGLIA. Their peripheral terminals (NERVE ENDINGS) innervate target tissues and transduce noxious stimuli via axons to the CENTRAL NERVOUS SYSTEM. Pain Receptors,Receptors, Pain,Nociceptive Neurons,Neuron, Nociceptive,Neurons, Nociceptive,Nociceptive Neuron,Nociceptor,Pain Receptor
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D012022 Reflex, Acoustic Intra-aural contraction of tensor tympani and stapedius in response to sound. Acoustic Reflex
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
October 1993, Molecular pharmacology,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
November 1993, The Journal of pharmacology and experimental therapeutics,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
April 1995, The Journal of pharmacology and experimental therapeutics,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
April 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
April 1995, European journal of pharmacology,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
October 1995, European journal of pharmacology,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
October 2000, Journal of medicinal chemistry,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
July 1997, The Journal of pharmacology and experimental therapeutics,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
November 1993, The Journal of pharmacology and experimental therapeutics,
K J Chang, and G C Rigdon, and J L Howard, and R W McNutt
February 1997, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!